[
    {
        "disorder": "Substance Use Disorder",
        "criteria": "A pathological pattern of behaviors related to use of the substance, manifested by at least two of the following within a 12-month period: 1) Substance often taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering from substance; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by substance; 10) Tolerance, defined by need for markedly increased amounts to achieve effect or diminished effect with continued use of same amount; 11) Withdrawal, manifested by characteristic withdrawal syndrome or substance taken to relieve or avoid withdrawal symptoms. Severity is based on number of criteria met: mild (2–3), moderate (4–5), severe (6 or more)."
    },
    {
        "disorder": "Alcohol Use Disorder",
        "criteria": "A problematic pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Alcohol often taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering from alcohol; 4) Craving or strong desire to use alcohol; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems caused or exacerbated by alcohol; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by alcohol; 10) Tolerance, as defined by need for markedly increased amounts or diminished effect with continued use; 11) Withdrawal, manifested by characteristic withdrawal syndrome or alcohol taken to relieve or avoid withdrawal symptoms."
    },
    {
        "disorder": "Alcohol Intoxication",
        "criteria": "Recent ingestion of alcohol; clinically significant problematic behavioral or psychological changes (e.g., inappropriate sexual or aggressive behavior, mood lability, impaired judgment) developing during or shortly after alcohol ingestion; one or more of the following signs or symptoms developing during or shortly after alcohol use: slurred speech, incoordination, unsteady gait, nystagmus, impairment in attention or memory, stupor or coma; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Alcohol Withdrawal",
        "criteria": "Cessation of or reduction in heavy and prolonged alcohol use; two or more of the following developing within several hours to a few days after cessation or reduction: autonomic hyperactivity (e.g., sweating, pulse rate >100 bpm), increased hand tremor, insomnia, nausea or vomiting, transient visual, tactile, or auditory hallucinations or illusions, psychomotor agitation, anxiety, generalized tonic-clonic seizures; signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Caffeine Intoxication",
        "criteria": "Recent consumption of caffeine (typically a high dose well in excess of 250 mg); five or more of the following signs or symptoms developing during or shortly after caffeine use: restlessness, nervousness, excitement, insomnia, flushed face, diuresis, gastrointestinal disturbance, muscle twitching, rambling flow of thought and speech, tachycardia or cardiac arrhythmia, periods of inexhaustibility, psychomotor agitation; signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Caffeine Withdrawal",
        "criteria": "Prolonged daily use of caffeine; abrupt cessation or reduction in caffeine use followed within 24 hours by three or more of the following: headache, marked fatigue or drowsiness, dysphoric mood/depressed mood/irritability, difficulty concentrating, flu-like symptoms (nausea, vomiting, muscle pain/stiffness); signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Cannabis Use Disorder",
        "criteria": "A problematic pattern of cannabis use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Cannabis often taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering from cannabis; 4) Craving or strong desire to use cannabis; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems caused or exacerbated by cannabis; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by cannabis; 10) Tolerance, defined by need for markedly increased amounts or diminished effect with continued use; 11) Withdrawal, manifested by characteristic withdrawal syndrome or cannabis taken to relieve or avoid withdrawal symptoms."
    },
    {
        "disorder": "Cannabis Intoxication",
        "criteria": "Recent use of cannabis; clinically significant problematic behavioral or psychological changes (e.g., impaired motor coordination, euphoria, anxiety, sensation of slowed time, impaired judgment, social withdrawal) developing during or shortly after cannabis use; two or more of the following signs or symptoms developing within 2 hours of cannabis use: conjunctival injection, increased appetite, dry mouth, tachycardia; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Cannabis Withdrawal",
        "criteria": "Cessation of heavy and prolonged cannabis use (usually daily or almost daily for at least a few months); three or more of the following signs and symptoms develop within approximately 1 week: irritability, anger or aggression; nervousness or anxiety; sleep difficulty (e.g., insomnia, disturbing dreams); decreased appetite or weight loss; restlessness; depressed mood; at least one physical symptom causing significant discomfort (abdominal pain, shakiness/tremors, sweating, fever, chills, or headache); signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Phencyclidine Use Disorder",
        "criteria": "A pattern of phencyclidine (or pharmacologically similar substance) use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by phencyclidine; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use. Withdrawal criterion does not apply."
    },
    {
        "disorder": "Phencyclidine Intoxication",
        "criteria": "Recent use of phencyclidine (or pharmacologically similar substance); clinically significant problematic behavioral changes (e.g., belligerence, assaultiveness, impulsiveness, unpredictability, psychomotor agitation, impaired judgment) developing during or shortly after use; within 1 hour, two or more of the following: vertical or horizontal nystagmus, hypertension or tachycardia, numbness or diminished responsiveness to pain, ataxia, dysarthria, muscle rigidity, seizures or coma, hyperacusis; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Other Hallucinogen Use Disorder",
        "criteria": "A problematic pattern of hallucinogen (other than phencyclidine) use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by hallucinogen; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use. Withdrawal criterion does not apply."
    },
    {
        "disorder": "Other Hallucinogen Intoxication",
        "criteria": "Recent use of a hallucinogen (other than phencyclidine); clinically significant problematic behavioral or psychological changes (e.g., marked anxiety or depression, ideas of reference, fear of losing one's mind, paranoid ideation, impaired judgment) developing during or shortly after use; perceptual changes occurring in a state of full wakefulness and alertness (e.g., subjective intensification of perceptions, depersonalization, derealization, illusions, hallucinations, synesthesias) developing during or shortly after use; two or more of the following signs developing during or shortly after use: pupillary dilation, tachycardia, sweating, palpitations, blurring of vision, tremors, incoordination; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Hallucinogen Persisting Perception Disorder",
        "criteria": "Following cessation of hallucinogen use, reexperiencing of one or more perceptual symptoms experienced while intoxicated (e.g., geometric hallucinations, false perceptions of movement in peripheral visual fields, flashes of color, intensified colors, trails of images of moving objects, positive afterimages, halos around objects, macropsia, micropsia); symptoms cause clinically significant distress or impairment; symptoms not attributable to another medical condition or better explained by another mental disorder; reality testing intact."
    },
    {
        "disorder": "Inhalant Use Disorder",
        "criteria": "A problematic pattern of use of a hydrocarbon-based inhalant substance leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by inhalant; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use. Withdrawal is not recognized as a criterion."
    },
    {
        "disorder": "Inhalant Intoxication",
        "criteria": "Recent intended or unintended short-term, high-dose exposure to inhalant substances; clinically significant problematic behavioral or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment) developing during or shortly after exposure; two or more of the following signs or symptoms developing during or shortly after inhalant use or exposure: dizziness, nystagmus, incoordination, slurred speech, unsteady gait, lethargy, depressed reflexes, psychomotor retardation, tremor, generalized muscle weakness, blurred vision or diplopia, stupor or coma, euphoria; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Opioid Use Disorder",
        "criteria": "A problematic pattern of opioid use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Opioids often taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by opioid; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use (not met if under appropriate medical supervision); 11) Withdrawal, manifested by characteristic withdrawal syndrome or opioids taken to relieve or avoid withdrawal symptoms (not met if under appropriate medical supervision)."
    },
    {
        "disorder": "Opioid Intoxication",
        "criteria": "Recent use of an opioid; clinically significant problematic behavioral or psychological changes (e.g., initial euphoria followed by apathy, dysphoria, psychomotor agitation or retardation, impaired judgment) developing during or shortly after opioid use; pupillary constriction (or dilation due to anoxia from severe overdose) and one or more of the following signs or symptoms developing during or shortly after opioid use: drowsiness or coma, slurred speech, impairment in attention or memory; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Opioid Withdrawal",
        "criteria": "Cessation of or reduction in heavy and prolonged opioid use or administration of opioid antagonist after opioid use; three or more of the following developing within minutes to several days: dysphoric mood, nausea or vomiting, muscle aches, lacrimation or rhinorrhea, pupillary dilation/piloerection/sweating, diarrhea, yawning, fever, insomnia; signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Sedative, Hypnotic, or Anxiolytic Use Disorder",
        "criteria": "A problematic pattern of sedative, hypnotic, or anxiolytic use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by substance; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use (not met if under medical supervision); 11) Withdrawal, manifested by characteristic withdrawal syndrome or substances taken to relieve or avoid withdrawal symptoms (not met if under medical supervision)."
    },
    {
        "disorder": "Sedative, Hypnotic, or Anxiolytic Intoxication",
        "criteria": "Recent use of a sedative, hypnotic, or anxiolytic; clinically significant maladaptive behavioral or psychological changes (e.g., inappropriate sexual or aggressive behavior, mood lability, impaired judgment) developing during or shortly after use; one or more of the following signs or symptoms developing during or shortly after use: slurred speech, incoordination, unsteady gait, nystagmus, impairment in cognition (attention, memory), stupor or coma; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Sedative, Hypnotic, or Anxiolytic Withdrawal",
        "criteria": "Cessation of or reduction in prolonged sedative, hypnotic, or anxiolytic use; two or more of the following developing within several hours to a few days: autonomic hyperactivity (e.g., sweating, pulse rate >100 bpm), hand tremor, insomnia, nausea or vomiting, transient visual, tactile, or auditory hallucinations or illusions, psychomotor agitation, anxiety, grand mal seizures; signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Stimulant Use Disorder",
        "criteria": "A pattern of amphetamine-type substance, cocaine, or other stimulant use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by stimulant; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use (not met if under medical supervision); 11) Withdrawal, manifested by characteristic withdrawal syndrome or stimulant taken to relieve or avoid withdrawal symptoms (not met if under medical supervision)."
    },
    {
        "disorder": "Stimulant Intoxication",
        "criteria": "Recent use of amphetamine-type substance, cocaine, or other stimulant; clinically significant problematic behavioral or psychological changes (e.g., euphoria or affective blunting, changes in sociability, hypervigilance, interpersonal sensitivity, anxiety, tension, or anger, stereotyped behaviors, impaired judgment) developing during or shortly after use; two or more of the following signs or symptoms developing during or shortly after use: tachycardia or bradycardia, pupillary dilation, elevated or lowered blood pressure, perspiration or chills, nausea or vomiting, evidence of weight loss, psychomotor agitation or retardation, muscular weakness, respiratory depression, chest pain, or cardiac arrhythmias, confusion, seizures, dyskinesias, dystonias, or coma; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Stimulant Withdrawal",
        "criteria": "Cessation of or reduction in prolonged amphetamine-type substance, cocaine, or other stimulant use; dysphoric mood and two or more of the following physiological changes developing within a few hours to several days: fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite, psychomotor retardation or agitation; signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Tobacco Use Disorder",
        "criteria": "A problematic pattern of tobacco use leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Tobacco often taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining or using tobacco; 4) Craving or strong desire to use tobacco; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems caused or exacerbated by tobacco; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by tobacco; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use; 11) Withdrawal, manifested by characteristic withdrawal syndrome or tobacco taken to relieve or avoid withdrawal symptoms."
    },
    {
        "disorder": "Tobacco Withdrawal",
        "criteria": "Daily use of tobacco for at least several weeks; abrupt cessation or reduction in tobacco use followed within 24 hours by four or more of the following: irritability, frustration, or anger; anxiety; difficulty concentrating; increased appetite; restlessness; depressed mood; insomnia; signs or symptoms cause clinically significant distress or impairment; not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Other (or Unknown) Substance Use Disorder",
        "criteria": "A problematic pattern of use of an intoxicating substance not classifiable within other substance categories leading to clinically significant impairment or distress, as manifested by at least two of the following within a 12-month period: 1) Substance often taken in larger amounts or over longer period than intended; 2) Persistent desire or unsuccessful efforts to cut down or control use; 3) Great deal of time spent obtaining, using, or recovering; 4) Craving or strong desire to use; 5) Recurrent use resulting in failure to fulfill major role obligations; 6) Continued use despite persistent or recurrent social or interpersonal problems; 7) Important social, occupational, or recreational activities given up or reduced; 8) Recurrent use in physically hazardous situations; 9) Use continued despite knowledge of persistent or recurrent physical or psychological problems caused or exacerbated by substance; 10) Tolerance as defined by need for markedly increased amounts or diminished effect with continued use; 11) Withdrawal, manifested by characteristic withdrawal syndrome or substance taken to relieve or avoid withdrawal symptoms."
    },
    {
        "disorder": "Other (or Unknown) Substance Intoxication",
        "criteria": "Development of a reversible substance-specific syndrome attributable to recent ingestion or exposure to a substance not listed elsewhere or unknown; clinically significant problematic behavioral or psychological changes attributable to the substance's effect on the CNS developing during or shortly after use; signs or symptoms not attributable to another medical condition or better explained by another mental disorder."
    },
    {
        "disorder": "Other (or Unknown) Substance Withdrawal",
        "criteria": "Cessation of or reduction in use of a substance that has been heavy and prolonged; development of a substance-specific syndrome shortly after cessation or reduction; syndrome causes clinically significant distress or impairment; symptoms not attributable to another medical condition or better explained by another mental disorder; substance involved cannot be classified under other substance categories or is unknown."
    },
    {
        "disorder": "Gambling Disorder",
        "criteria": "Persistent and recurrent problematic gambling behavior leading to clinically significant impairment or distress, as indicated by four or more of the following within a 12-month period: 1) Needs to gamble with increasing amounts of money to achieve desired excitement; 2) Restless or irritable when attempting to cut down or stop gambling; 3) Repeated unsuccessful efforts to control, cut back, or stop gambling; 4) Often preoccupied with gambling; 5) Often gambles when feeling distressed; 6) After losing money gambling, often returns another day to get even ('chasing' losses); 7) Lies to conceal extent of involvement; 8) Jeopardized or lost significant relationship, job, or educational/career opportunity because of gambling; 9) Relies on others to provide money to relieve desperate financial situations caused by gambling; gambling behavior not better explained by a manic episode."
    }
]